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To determine whether Saccharomyces cerevisiae can serve as a host for efficient carotenoid and especially
-carotene production, carotenogenic genes from the carotenoid-producing yeast Xanthophyllomyces dendror-
hous were introduced and overexpressed in S. cerevisiae. Because overexpression of these genes from an
episomal expression vector resulted in unstable strains, the genes were integrated into genomic DNA to yield
stable, carotenoid-producing S. cerevisiae cells. Furthermore, carotenoid production levels were higher in
strains containing integrated carotenogenic genes. Overexpression of crtYB (which encodes a bifunctional
phytoene synthase and lycopene cyclase) and crtI (phytoene desaturase) from X. dendrorhous was sufficient to
enable carotenoid production. Carotenoid production levels were increased by additional overexpression of a
homologous geranylgeranyl diphosphate (GGPP) synthase from S. cerevisiae that is encoded by BTS1. Com-
bined overexpression of crtE (heterologous GGPP synthase) from X. dendrorhous with crtYB and crtI and
introduction of an additional copy of a truncated 3-hydroxy-3-methylglutaryl–coenzyme A reductase gene
(tHMG1) into carotenoid-producing cells resulted in a successive increase in carotenoid production levels. The
strains mentioned produced high levels of intermediates of the carotenogenic pathway and comparable low
levels of the preferred end product -carotene, as determined by high-performance liquid chromatography. We
finally succeeded in constructing an S. cerevisiae strain capable of producing high levels of -carotene, up to
5.9 mg/g (dry weight), which was accomplished by the introduction of an additional copy of crtI and tHMG1 into
carotenoid-producing yeast cells. This transformant is promising for further development toward the biotech-
nological production of -carotene by S. cerevisiae.
Carotenoids are a class of pigments of commercial interest
that have important biological functions. In humans, -caro-
tene is the precursor of vitamin A; it may function as an
antioxidant, has properties protective against cancer, and stim-
ulates the immune system (14, 22, 32). Because carotenoids are
colored compounds, they are being used as pigments in the
food and feed industries (20). Many carotenoids are being
produced by chemical synthesis, which yields products that are
pure and cheap (10). Several microorganisms, including fungi,
bacteria, and algae, are able to produce carotenoids naturally
(12). Biotechnological synthesis of certain carotenoids, by ei-
ther homologous or heterologous production, may become
more and more attractive (15, 17). One example of a carot-
enoid-producing yeast is the red yeast Xanthophyllomyces den-
drorhous, which was formerly known as Phaffia rhodozyma (9).
This yeast mainly produces the carotenoid astaxanthin but also
accumulates some -carotene as an intermediate of the asta-
xanthin biosynthesis pathway (1, 7, 35). The genes involved in
-carotene production in X. dendrorhous have been cloned
previously (33, 34). In X. dendrorhous, the ergosterol and carot-
enoid biosynthetic pathways are connected by their utilization
of prenyl diphosphates (Fig. 1). Farnesyl diphosphate (FPP) is
converted into geranylgeranyl diphosphate (GGPP) by GGPP
synthase, which is encoded by crtE. Next, the phytoene syn-
thase activity of the bifunctional enzyme CrtYB results in the
synthesis of phytoene from two GGPP molecules. Phytoene is
subsequently converted into lycopene by four desaturation re-
actions catalyzed by the enzyme CrtI. Subsequently, two cycli-
zation reactions catalyzed by CrtYB result in the conversion of
lycopene into -carotene and finally into -carotene. X. den-
drorhous mutants with higher carotenoid production capacities
have been obtained by chemical mutagenesis (1, 7) or by re-
combinant DNA technology (35, 39).
The food yeast Saccharomyces cerevisiae is widely used in the
brewing and fermentation industries; it is generally recognized
as safe and can be used for the production of biomass rich in
high-quality proteins and metabolites. Furthermore, it has the
advantage of easy genetic manipulation with established host-
vector systems (2, 21). In order to transform S. cerevisiae into
a -carotene-producing organism, precursors of carotenoids
should be present. Like X. dendrorhous, S. cerevisiae is able to
produce FPP and converts it into GGPP, the basic building
block of carotenoids. Conversion of FPP into GGPP is cata-
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lyzed by GGPP synthase encoded by BTS1 in S. cerevisiae (11;
Fig. 1). Therefore, overexpression of only crtYB and crtI from
X. dendrorhous in S. cerevisiae should generally be sufficient to
transform S. cerevisiae into a -carotene-producing organism.
Additional overexpression of crtE from X. dendrorhous or
BTS1 from S. cerevisiae might increase GGPP levels and
thereby enhance -carotene production. In an initial effort to
produce -carotene heterologously in S. cerevisiae, the caroteno-
genic genes crtE, crtB, crtI, and crtY from the bacterium
Erwinia uredovora were introduced and overexpressed from
episomal vectors with different yeast-derived promoters and
terminators for each gene. This resulted in quite low -caro-
tene production levels of 103 g/g (dry weight [dw]) (41).
Overexpression of the same genes in the food yeast Candida
utilis resulted in higher -carotene production levels of 400
g/g (dw) (18). Additional overexpression of the catalytic do-
main of 3-hydroxy-3-methylglutaryl–coenzyme A (HMG-CoA)
reductase from C. utilis, which is considered to be a key regu-
latory step in ergosterol biosynthesis in yeasts (4), resulted in a
7.1-fold increase in lycopene content. The effect of HMG-CoA
reductase on -carotene production was not examined (29).
Attempts to produce carotenoids heterologously in Esche-
richia coli by using genes from X. dendrorhous resulted in poor
enzyme expression and carotenoid production (G. Sandmann,
unpublished results). Although heterologous carotenoid pro-
duction in S. cerevisiae has already been studied by using bac-
terial genes from E. uredovora, we expect that -carotene pro-
duction levels will be much higher with genes from another
yeast species. Therefore, we have constructed a series of carot-
enoid-producing S. cerevisiae strains by successive introduc-
tion and overexpression of carotenogenic genes from X. den-
drorhous.
MATERIALS AND METHODS
Vector construction and transformation. Episomal and integration vectors
were constructed as depicted in Fig. 2a. The genes crtYB, crtI, and crtE were
amplified with a cDNA library from X. dendrorhous as the template (36) and
primers indicated in Table 1. The sequences of the carotenogenic genes
can be accessed at NCBI (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db
Nucleotide&itooltoolbar). The BTS1 gene was amplified with genomic DNA
prepared from S. cerevisiae strain CEN.PK 113-7D and primers indicated in
Table 1. Standard PCR conditions and the proofreading enzyme super TAQ plus
(SphaeroQ, Gorinchem, The Netherlands) were used in all PCRs, except for
site-directed mutagenesis. The amplified PCR products were verified by se-
quencing. The crtYB, crtI, crtE, and BTS1 PCR products were BamHI/SalI ligated
into vector p426GPD, containing 680 bp of the promoter region upstream of the
start codon of the TDH3 gene and the first 250 bp of the CYC1 terminator from
S. cerevisiae (19). Subsequently, TDH3 promoter-gene-CYC1 terminator prod-
FIG. 1. Overview of the ergosterol biosynthetic pathway in S. cerevisiae and the carotenogenic pathway in X. dendrorhous. The carotenogenic
pathway in X. dendrorhous consists of GGPP synthase encoded by crtE, the bifunctional enzyme phytoene synthase and lycopene cyclase encoded
by crtYB, and phytoene desaturase encoded by crtI. S. cerevisiae contains a GGPP synthase, encoded by BTS1, which is able to convert FPP into
GGPP. HMG1 encodes HMG-CoA reductase, which is the main regulatory point in the ergosterol biosynthetic pathway in many organisms. IPP,
isopentenyl diphosphate; DMAP, dimethylallyl diphosphate; GPP, geranyl diphosphate.
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ucts were amplified by PCR with the primers indicated in Table 1 (Isogen Life
Science, IJsselstein, The Netherlands). To construct episomal expression vectors,
TDH3p-crtE-CYC1t was EcoRI ligated into vector YEplac195 (6). Next, TDH3p-
crtYB-CYC1t was PstI ligated and TDH3p-crtI-CYC1t was KpnI ligated into
YEplac195E, resulting in vector YEplac195YB/I/E. To construct YEplac195YB/
I/BTS1, in sequential order TDH3p-BTS1-CYC1t was SmaI ligated, TDH3p-
crtYB-CYC1t was PstI ligated, and TDH3p-crtI-CYC1t was KpnI ligated into
YEplac195. To construct YEplac195YB/I, YEplac195YB/I/E was restricted with
EcoRI and the remaining vector was self-ligated. For targeted integration into
the ura3-52 locus, integrative vectors were constructed (6). Targeted integration
into the ura3-52 locus requires linearization of vector YIplac211 with StuI. The
StuI restriction site present in the coding sequence of crtE was eliminated by
site-directed mutagenesis. A at position 551 was mutated to G with vector
YEplac195E as the template and the primers indicated in Table 1 (for the
procedure used, see reference 37). THD3p-crtE*-CYC1t (* denotes the A-to-G
mutation) was EcoRI ligated into YEplac195YB/I/E restricted with EcoRI. The
2m part of YEplac195 was eliminated by ligating a 694-bp EheI/StuI fragment
from vector YIplac211 into YEplac195YB/I/E*, YEplac195YB/I/BTS1, and
YEplac195YB/I, which were restricted by EheI/StuI (6). In this manner, tandem
head-to-tail orientation of the genes introduced was maintained. All promoter-
gene-terminator fusions were indeed present in tandem head-to-tail orientation
on the YEplac and YIplac expression vectors, as determined by restriction
analysis and shown schematically in Fig. 2b. The YIplac211 vectors containing
carotenogenic genes were linearized with StuI and transformed into strain
CEN.PK 113-5D to create strains YB/I/BTS1 and YB/I/E. Single-copy integra-
tion of the constructs was confirmed by Southern blotting by standard laboratory
procedures (27). To create vector YIplac128 crtI, vector YEplac195YB/I was
restricted with KpnI and the TDH3p-crtI-CYC1t fragment was ligated into
YIplac128 (6). For overexpression of the catalytic domain of HMG-CoA reductase
(tHMG1 for truncated HMG1), the 1,575-bp C-terminal part of HMG1 was
amplified with primers tHMG1-F and tHMG1-R and S. cerevisiae genomic DNA
as the template. In the forward primer, a start codon (ATG) was included.
Amplified tHMG1 was SpeI/XhoI ligated into vector p426 GPD (19). Subse-
quently, TDH3p-tHGM1-CYC1t was amplified with primers Pr-tHMG1-Tr-F and
Pr-tHMG1-Tr-F and PstI ligated into YIplac204 (6) to create YIplac204 tHMG1.
To create strain YB/I/E  extra I, YIplac128 crtI was linearized with ClaI for
targeted integration into the leu2,3-112 locus. To create strain YB/I/E  tHMG1,
YIplac204 tHMG1 was linearized with EcoRV to target integration into the
FIG. 2. Construction of expression vectors used in this study. (a) Scheme representing the construction of the different vectors used in this
study. GPDp is the 680-bp sequence of the TDH3 promoter, and CYC1t is the 250-bp sequence of the CYC1 terminator. Restriction enzyme
abbreviations: B, BamHI; Sa, SalI; E, EcoRI; P, PstI; K, KpnI; S, SmaI. Sequences used for primers are indicated in Table 1. Integration into the
ura3-52 locus requires linearization of the YIplac211 constructs with StuI. Because crtE contains a StuI restriction site, A at position 551 was
changed into G by site-directed mutagenesis (indicated by an asterisk). See Materials and Methods for details concerning the cloning strategy used.
(b) Orientation of the carotenogenic genes in the vectors used in this study, as determined by restriction analysis. All genes are present in tandem
head-to-tail orientation on the expression vectors.
TABLE 1. PCR and qPCR primers used in this study and referred to in Fig. 2a
Primer Sequence (5 to 3)
For PCR
crtYB-F...................................................................................................................CGCGGATCCATGACGGCTCTCGCATATTAC
crtYB-R ..................................................................................................................TGCGGTCGACTTACTGCCCTTCCCATCCGC
crtI-F .......................................................................................................................GCGGGATCCATGGGAAAAGAACAAGATCAGG
crtI-R ......................................................................................................................TGCGGTCGACTCAGAAAGCAAGAACACCAACG
crtE-F......................................................................................................................CGCGGATCCATGGATTACGCGAACATCCTC
crtE-R .....................................................................................................................TGCGGTCGACTCACAGAGGGATATCGGCTAG
BTS1-F....................................................................................................................CGCGGATCCATGGAGGCCAAGATAGATGAG
BTS1-R...................................................................................................................TGCGGTCGACTCACAATTCGGATAAGTGGTCT
Pr-crtYB-Tr-F ........................................................................................................AAAACTGCAGCAGTTCGAGTTTATCATTATCAAT
Pr-crtYB-Tr-R .......................................................................................................TTTTCTGCAGGCGGCCGCGCAAATTAAAGCCTTCGAGCG
Pr-crtI-Tr-F ............................................................................................................CGGGGTACCCAGTTCGAGTTTATCATTATCAAT
Pr-crtI-Tr-R............................................................................................................GCCGGTACCGGCCGGCCGCAAATTAAAGCCTTCGAGCG
Pr-crtE-Tr-F ...........................................................................................................GGAATTCCAGTTCGAGTTTATCATTATCAAT
Pr-crtE-Tr-R ..........................................................................................................CGAATTCGGCGCGCCGCAAATTAAAGCCTTCGAGCG
Pr-BTS1-Tr-F.........................................................................................................TCCCCCGGGCAGTTCGAGTTTATCATTATCAAT
Pr-BTS1-Tr-R ........................................................................................................AGGCCCGGGGGCGCGCCGCAAATTAAAGCCTTCGAGCG
crtE (551 A-to-G mutation)-F.............................................................................CCATAGAGGGCAGGGCCTGGAGCTATTC
crtE (551 A-to-G mutation)-R ............................................................................GAATAGCTCCAGGCCCTGCCCTCTATGG
tHMG1-F................................................................................................................GGACTAGTATGGACCAATTGGTGAAAACTGAAG
tHMG1-R...............................................................................................................CCGCTCGAGTTAGGATTTAATGCAGGTGACG
Pr-tHMG1-Tr-F.....................................................................................................AAAACTGCAGCAGTTCGAGTTTATCATTATCAAT
Pr-tHMG1-Tr-R ....................................................................................................TTTTCTGCAGGCGGCCGCGCAAATTAAAGCCTTCGAGCG
For qPCR
ACT1-F...................................................................................................................GCCTTGGACTTCGAACAAGA
ACT1-R ..................................................................................................................CCAAACCCAAAACAGAAGGA
crtYB-F...................................................................................................................TAGTCGCCTACGCAGAGGAT
crtYB-R ..................................................................................................................TCTCTCCGACGTCTCCTTTC
crtI-F .......................................................................................................................GGGCTGACTTAGTTGGTGGA
crtI-R ......................................................................................................................TTGTGTCGAATGATCCCTTG
crtE-F......................................................................................................................CACAGAAACCCACTCATTCG
crtE-R .....................................................................................................................GTTCTTCCCCGTTCTTCCTT
BTS1-F....................................................................................................................CGAAAGGTCAAACTGAGCAAC
BTS1-R...................................................................................................................GCGAAGCCAAATCAGGTAAA
a Underlined letters indicate restriction enzyme cleavage sites corresponding to the primer description. Bold letters indicate the A-to-G mutation in the crtE gene.
Bold and underlined letters indicate the start codon created for tHMG1.
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trp1-289 locus. The linearized vectors were transformed into S. cerevisiae strain
CEN.PK 113-6B previously transformed with YIplac211 YB/I/E*. To create
strain YB/I/E  tHMG1  extra I, strain YB/I/E  tHMG1 was transformed
with ClaI-linearized YIPlac128 crtI for targeted integration into the leu2,3-112
locus. All constructs were transformed into yeast by electroporation (3). The
constructs created in this study are indicated in Table 2.
Strains and media. The S. cerevisiae strains used in this study are indicated in
Table 2. During batch culture, experiments yeast cells were grown on yeast
nitrogen base (YNB) without amino acids (Difco, Boom, The Netherlands),
supplemented with the appropriate amino acids when required and 2% (wt/vol)
D-glucose. Cells were grown at 225 rpm and 30°C in a shaking incubator.
Carotenoid analysis. Cells were resuspended in 1 ml sterile water, 1 g 0.50- to
0.75-mm glass beads was added, and cells were broken by vortexing for 3 min. A
2.5-ml volume of 0.2% (wt/vol) pyrogallol dissolved in methanol was added, and
cells were vortexed for 10 s. After adding 1.25 ml 60% (wt/vol) KOH and
vortexing for 10 s, the cells were incubated for 1 h at 75°C with vortexing every
15 min for saponification. Next, an appropriate amount of hexane was added to
extract the carotenoid fraction. The tubes were centrifuged for 5 min at 2,800
rpm, and 1 ml of the hexane was pipetted into a cuvette. Absorption between 550
and 400 nm was monitored on a Shimadzu UV-2501 PC spectrophotometer
(Shimadzu, Duisburg, Germany) to measure the amounts of colored carotenoids.
A standard curve was determined by measuring known -carotene concentra-
tions. The total colored carotenoid concentration was calculated by the following
formula: total carotenoids (in g g1 [dw])  (A449  ml hexane)/(0.2072  g
[dw]). An aliquot of the total carotenoid extractions was evaporated under
nitrogen in the dark for subsequent analysis of the carotenoid composition by
high-performance liquid chromatography (HPLC). HPLC separation and quan-
tization were performed on a Nucleosil C18 3-m column eluted isocratically
with acetonitrile–methanol–2-propanol (50:40:10, vol/vol) at a flow rate of 1 ml
min1 (30). The separated carotenoids were detected with a Kontron 440 diode
array detector and spectra were directly recorded online. Reference compounds
for identification and quantitation were generated in transgenic E. coli cells (28).
The dw of a sample was measured by taking the same culture volume as used for
the carotenoid extraction, drying it overnight at 80°C, and measuring the weight
of the dried yeast cells on an analytical balance.
qPCR studies. Total RNA was isolated as previously described (38). To ensure
similar amounts of starting materials, total RNA concentrations were carefully
measured with a Nanodrop ND-1000 spectrophotometer (Nanodrop Technolo-
gies Inc.). Next, chromosomal DNA was degraded by treatment with DNase I
(amplification grade; Invitrogen) according to the manufacturer’s instructions.
Subsequently, cDNA was amplified with an Omniscript RT kit (QIAGEN,
Venlo, The Netherlands) with the following modifications. A 10 mM de-
oxynucleoside triphosphate stock (Promega) and an Oligo-dT18 primer (Isogen
Life Science, IJsselstein, The Netherlands) were used in the reaction mixtures.
Pipetting was performed by a pipetting robot (Corbett Robotics), with the am-
plified cDNA, the quantitative PCR (qPCR) primers as indicated in Table 1, and
ABsolute QPCR SYBR green mix (ABgene). These qPCR primers were de-
signed with Primer3 (26). The qPCRs were performed in a Rotor Gene RG-3000
real-time PCR machine (Corbett Research). To correct for differences in the
amounts of starting materials, ACT1 was chosen as a reference housekeeping
gene. The results are presented as ratios of gene expression between the target
gene (gene of interest) and the reference gene, ACT1 (23).
RESULTS AND DISCUSSION
Transformation with episomal vectors. To determine
whether S. cerevisiae is able to produce carotenoids, caroteno-
genic genes from X. dendrorhous were initially overexpressed
from episomal vectors. Expression of each of the genes intro-
duced was controlled by the constitutive TDH3 promoter and
the CYC1 terminator (19). Overexpression of crtYB and crtI
with YEplac195 resulted in faintly yellow transformants. Ad-
ditional overexpression of the GGPP synthase BTS1 from S.
cerevisiae or crtE from X. dendrorhous resulted in orange cells.
When grown in YNB 2% glucose medium, all transformants
reached optimal densities similar to the optical density of wild-
type cells, indicating that carotenoid production in S. cerevisiae
TABLE 2. Yeast strains and plasmids used in this studya
Yeast strain or plasmid Relevant features
Yeast strains
CEN.PK 113-7Db .............................................................................MATa SUC2 MAL2-8c
CEN.PK 113-5Db .............................................................................MATa SUC2 MAL2-8c ura3-52
CEN.PK 113-6Bb ..............................................................................MATa SUC2 MAL2-8c ura3-52 leu2,3-112 trp1-289
Episomal vector transformants
YB/I....................................................................................................CEN.PK 113-5D  YEplac195 YB/I
YB/I/BTS1.........................................................................................CEN.PK 113-5D  YEplac195 YB/I/BTS1
YB/I/E................................................................................................CEN.PK 113-5D  YEplac195 YB/I/E
YB/I/E*..............................................................................................CEN.PK 113-5D  YEplac195 YB/I/E*
Integrative vector transformants
YB/I/BTS1.........................................................................................CEN.PK 113-5D  YIplac211 YB/I/BTS1
YB/I/E................................................................................................CEN.PK 113-5D  YIplac211 YB/I/E*
YB/I/E  extra I ..............................................................................CEN.PK 113-6B  YIplac211 YB/I/E*  YIplac128 crtI
YB/I/E  tHMG1 ............................................................................CEN.PK 113-6B  YIplac211 YB/I/E*  YIplac204 tHMG1
YB/I/E  tHMG1  extra I...........................................................CEN.PK 113-6B  YIplac211 YB/I/E*  YIplac204 tHMG1  YIplac128 crtI
Plasmids
YEplac195 YB/I ...............................................................................YEplac195 TDH3p-crtYB-CYC1t; TDH3p-crtI-CYC1t
YEplac195 YB/I/BTS1.....................................................................YEplac195 TDH3p-crtYB-CYC1t; TDH3p-crtI-CYC1t; TDH3p-BTS1-CYC1t
YEplac195 YB/I/E ...........................................................................YEplac195 TDH3p-crtYB-CYC1t; TDH3p-crtI-CYC1t; TDH3p-crtE-CYC1t
YEplac195 YB/I/E* .........................................................................YEplac195 TDH3p-crtYB-CYC1t; TDH3p-crtI-CYC1t; TDH3p-crtE*-CYC1t
YIplac211 YB/I/BTS1......................................................................YIplac211 TDH3p-crtYB-CYC1t; TDH3p-crtI-CYC1t; TDH3p-BTS1-CYC1t
YIplac211 YB/I/E*...........................................................................YIplac211 TDH3p-crtYB-CYC1t; TDH3p-crtI-CYC1t; TDH3p-crtE*-CYC1t
YIplac128 crtI ...................................................................................YIplac128 TDH3p-crtI-CYC1t
YIplac204 tHMG1 ............................................................................YIplac204 TDH3p-tHMG1-CYC1t
a The asterisk indicates the 551A-to-G mutation in the crtE coding sequence. Functional genes are in uppercase italics; nonfunctional ones are in lowercase italics.
Promoters and terminators are represented as follows: TDH3p, TDH3 promoter; CYC1t, CYC1 terminator. For targeted integration, integrative (YIplac) plasmids were
transformed as described in Materials and Methods.
b Institut fu¨r Mikrobiologie, J. W. Goethe Universita¨t, Frankfurt am Main, Germany.
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does not influence growth (data not shown). After centrifuga-
tion, cells overexpressing crtYB and crtI were faintly yellow,
cells overexpressing crtYB, crtI, and BTS1 were yellow, and
cells that overexpressed crtYB, crtI, and crtE were orange.
HPLC studies confirmed that carotenoids were produced in
cells overexpressing crtYB and crtI (3 g total carotenoids/g
[dw]) and that additional overexpression of BTS1 resulted in a
28-fold increase in carotenoid production (83 g/g [dw]).
Overexpression of crtYB, crtI, and crtE resulted in 162-fold
higher total carotenoid levels compared to cells overexpressing
crtYB and crtI (487 g/g [dw]; Table 3). It was expected that
overexpression of carotenogenic genes from X. dendrorhous
would yield S. cerevisiae cells producing high levels of pure
-carotene. However, HPLC studies showed that besides
-carotene, cells overexpressing crtYB and crtI also produced
phytoene and cells overexpressing crtYB, crtI, and BTS1 addi-
tionally produced phytoene and dihydro--carotene (a cycliza-
tion product of neurosporene). Phytoene, neurosporene, and
lycopene were also accumulated in cells overexpressing crtYB,
crtI, and crtE (Table 3).
It was observed that about 10% of the cells transformed with
episomal vectors lost their color after growth for 3 days in YNB
medium and subsequent growth for 3 days on agar plates (data
not shown). This result suggested instability of the strain or
instability of the expression vector. Episomal expression vec-
tors tend to be structurally unstable, especially when they con-
tain large inserts (42). This was indeed confirmed by extraction
of the expression vectors containing carotenogenic genes from
white yeast cells and subsequent restriction analysis to deter-
mine the presence of the introduced genes on the vector (data
not shown). To avoid the problem of instability, integrative
vectors were used to generate a new series of transformants.
Transformation with integrative vectors. To create geneti-
cally stable carotenoid-producing S. cerevisiae cells, integrative
vectors were constructed as indicated in Fig. 2. Because inte-
gration into the ura3-52 locus required linearization of the
vectors with StuI, which is present within the coding sequence
of crtE, the StuI restriction site within the crtE gene was
changed by site-directed mutagenesis. This mutation did not
influence carotenoid accumulation (data not shown). Con-
structs containing different combinations of carotenogenic
genes were integrated into genomic DNA. Integration of crtYB
and crtI resulted in faintly yellow colonies, additional integra-
tion of crtE resulted in orange cells and integration of crtYB,
crtI, and BTS1 resulted in yellow cells. Transformants were
grown overnight in YNB medium and subsequently streaked
onto nonselective agar plates. Less than 0.5% of the cells lost
their color after 3 days of incubation, indicating that the sta-
bility of carotenoid-producing S. cerevisiae cells is greatly in-
creased by genomic integration of carotenogenic genes. Be-
cause YB/I cells produced very low levels of carotenoids, this
strain was excluded from further studies. To determine the
exact composition of the accumulated carotenoids, cells were
grown for 72 h in liquid cultures and HPLC studies were
performed (Table 4). The growth properties of YB/I/E and
YB/I/BTS1 cells were similar compared to those of wild-type
cells (data not shown). Carotenoid production levels were
higher in cells containing integrated carotenogenic genes com-
pared to expression from episomal vectors (Tables 3 and 4).
Copy numbers of episomal (YEplac) vectors are, in general,
higher compared to those of integrative (YIplac) vectors (25),
suggesting that higher protein levels and hence higher carotenoid
production levels should be obtained. Results similar to ours
were obtained with E. coli, where higher -carotene produc-
tion was obtained with a low-copy-number vector compared to
a high-copy-number vector (13). The use of high-copy-number
plasmids increases the demand for nucleotides during plasmid
replication and might result in metabolic burden issues (8),
resulting in decreased carotenoid production levels. Further-
more, it was observed that total carotenoid levels were higher
TABLE 3. Carotenoid compositions of S. cerevisiae strain
transformed with the episomal vector YEplac195
containing different carotenogenic genes
Carotenoid
Specific amt (g/g 	dw
)
(% distribution) of carotenoidsa
YB/I YB/I/BTS1 YB/I/E
Phytoene 1 (33) 61 (73) 310 (64)
Neurosporene —b — 13 (3)
Lycopene — — 79 (16)
-Carotene 2 (67) 13 (16) 85 (17)
7,8-Dihydro--carotene — 9 (11) —
Total 3 83 (28) 487 (162)
a The data are averages of two independent cultures. The n-fold increases in
total carotenoid production levels compared to that of strain YB/I are in paren-
theses in the bottom row (the value for strain YB/I is set at 1).
b —, not detected.
TABLE 4. Carotenoid compositions of S. cerevisiae strains containing integrated carotenogenic gene overexpression cassettes and an
additional crtI overexpression cassette, an additional tHMG1 overexpression cassette, or both
Carotenoid
Specific amt (g/g 	dw
) (% distribution) of carotenoidsa
YB/I/BTS1 YB/I/E YB/I/EtHMG1 YB/I/EI YB/I/EtHMG1I
Phytoene 476 (94) 1,323 (86) 10,302 (92) 682 (29) 5,380 (48)
Neurosporene 3 (0.5) 5 (0.5) 48 (0.5) 75 (3) —b
-Carotene 15 (3) 141 (9) 501 (4.5) 1,627 (68) 5,918 (52)
-Zeacarotene 4 (0.5) 16 (1) 109 (1) — —
7,8-Dihydro--carotene 10 (2) 60 (3.5) 262 (2) — —
Total 508 (33) 1,545 (100) 11,222 (726) 2,384 (154) 11,298 (731)
a The data are averages of two independent cultures, except for YB/I/EtHMG1I, which are triplicates. The relative total carotenoid production levels compared
to that of the YB/I/E strain are in parentheses in the bottom row (the value for strain YB/I/E is set at 100%).
b —, not detected.
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in YB/I/E cells compared to YB/I/BTS1 cells (Tables 3 and 4).
This might be caused by differences in substrate specificity for
CrtE and Bts1. It has been reported that CrtE from E. ure-
dovora uses both FPP and GPP as substrates (40), which might
be similar for CrtE from X. dendrorhous. Only FPP can serve as
a substrate for Bts1 (11). The ability to use both FPP and GPP
as precursors might lead to higher carotenoid production lev-
els. In both strains, about 90% of the produced carotenoids
consisted of phytoene, whereas small amounts of neuros-
porene, -zeacarotene, and 7,8-dihydro--carotene were also
present (Table 4). It has been shown that overexpression of
lycopene cyclase (crtY) from E. uredovora or Capsicum an-
nuum in carotenoid-producing E. coli cells resulted in produc-
tion of the bicyclic carotenoid 7,8-dihydro--carotene via
monocyclic -zeacarotene and neurosporene (31). Formation
of these carotenoids in our carotenoid-producing S. cerevisiae
strains is probably the result of the high cyclase activity of
CrtYB (Fig. 1).
Accumulation of intermediates indicated that the flux
through the carotenogenic pathway was not fully efficient. The
high levels of phytoene and other intermediates with a degree
of desaturation lower than that of -carotene in YB/I/BTS1
and YB/I/E cells suggest that the phytoene desaturation reac-
tion might be the bottleneck in heterologous -carotene pro-
duction by S. cerevisiae. This could be caused by poor tran-
scription or translation efficiency of crtI or poor activity of the
phytoene desaturase protein in S. cerevisiae. Accumulation of
intermediates was not observed in the production of carotenoids
in E. coli with the carotenogenic genes from E. uredovora (16).
However, in S. cerevisiae cells overexpressing carotenogenic
genes from E. uredovora on episomal vectors, intermediates
also accumulated; 78% of the total carotenoids consisted of
-carotene, 11% accumulated as phytoene, and 11% accumu-
lated as lycopene (41). Apparently, phytoene desaturation be-
comes a rate-limiting step in heterologous -carotene produc-
tion by S. cerevisiae when using carotenogenic genes from X.
dendrorhous or E. uredovora. Accumulation of phytoene was
also observed in a lycopene-producing C. utilis strain trans-
formed with carotenogenic genes from E. uredovora (18). It
was suggested that yeast membrane environments in which the
conversion of phytoene into lycopene is likely to occur are not
suitable for an efficient desaturation reaction. Suitable electron
carriers, required for the dehydrogenation reaction, might be
absent. It was presumed that active proteins would be present
because of the presence of carotenogenic gene transcripts (18).
To determine whether the integrated carotenogenic genes in
our strains were correctly expressed, qPCR studies were per-
formed (Fig. 3). In wild-type cells, no signal was obtained with
primers to detect the expression of crtYB, crtI, and crtE,
whereas the GGPP synthase BTS1 was expressed at a low level.
In YB/I/E cells, quite high expression of crtYB, crtI, and crtE
and low expression of BTS1 were detected. In YB/I/BTS1 cells,
no expression of crtE was detected, whereas crtYB, crtI, and
BTS1 were expressed at high levels compared to the house-
keeping gene ACT1, which encodes actin. In both YB/I/E and
YB/I/BTS1 cells, the relative expression levels of crtI were the
highest of the carotenogenic genes introduced. The results
from the qPCR studies indicated that the high phytoene levels
were presumably not caused by poor crtI transcription effi-
ciency.
Additional overexpression of crtI in strain YB/I/E. Although
high accumulation of phytoene was not caused by low crtI
transcription levels, we tested whether additional overexpres-
sion of the crtI gene and integration at another locus in YB/I/E
cells would have an effect on phytoene and -carotene levels.
The TDH3p-crtI-CYC1t cassette was integrated into the leu2,3-
112 locus in YB/I/E cells. An increased copy number might
result in higher levels of the phytoene desaturase protein and
FIG. 3. qPCR studies to determine overexpression of carotenogenic genes in carotenoid-producing yeast strains. Three cultures of each strain,
the wild type, YB/I/E, and YB/I/BTS1, were inoculated in YNB with 2% glucose at the same optical density. Six hours after inoculation, samples
were taken and further processed for cDNA synthesis. qPCR experiments were performed to determine the relative abundances of crtYB, crtI, crtE,
and BTS1 in each strain with respect to that of ACT1, which encodes actin and served as an internal control. The data represent the average and
standard deviation of three independently grown cultures.
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could lead to more efficient conversion of phytoene into down-
stream products of the carotenogenic pathway. The transfor-
mants displayed a more orange color compared to that of
YB/I/E cells (Fig. 4a and b). Subsequent HPLC studies re-
vealed that overexpression of crtI in strain YB/I/E resulted in a
1.5-fold increase in the total carotenoid levels compared to
those of strain YB/I/E (Table 4). The major difference was a
decrease in phytoene accumulation (86% to 29% of the total
carotenoid levels) and an increase in -carotene accumulation
(9% to 68% of the total carotenoid levels), yielding -carotene
levels of around 1.5 mg/g (dw). Apparently, additional overex-
pression of crtI in a strain overexpressing crtYB, crtI, and crtE
resulted in increased desaturation of phytoene and greatly
improved the flux toward -carotene. Possibly, the amount of
CrtI protein should reach a certain level in order to efficiently
convert phytoene into lycopene in the membrane environment
of S. cerevisiae. This level might be reached after additional
introduction and overexpression of the crtI gene.
Overexpression of the catalytic domain of HMG1 in strain
YB/I/E. It has been shown that the flux through the ergosterol
biosynthetic pathway, which is related to the carotenoid path-
way by prenyl diphosphate utilization, can be increased by
overexpression of the catalytic domain of HMG-CoA reduc-
tase (tHMG1) in S. cerevisiae (5, 24). Furthermore, overexpres-
sion of tHMG1 from C. utilis in C. utilis cells heterologously
producing lycopene resulted in increased lycopene production,
probably by increasing the supply of precursors (29). There-
fore, it was determined whether overexpression of tHMG1
could increase carotenoid production in carotenoid-producing
S. cerevisiae cells. For this purpose, the TDH3p-tHMG1-CYC1t
cassette was integrated into the trp1-289 locus in YB/I/E cells.
Transformation of tHMG1 resulted in a clear color difference;
YB/I/E cells were orange, and YB/I/EtHMG1 cells were
yellow (Fig. 4a and c). Overexpression of the catalytic domain
of Hmg1 results in a sevenfold increase in total carotenoid
levels compared to those of YB/I/E cells (Table 4). This in-
crease in total carotenoid accumulation is largely caused by a
massive increase in phytoene levels, up to 10 mg/g (dw), which
suggested that desaturation of phytoene is limiting without
additional crtI overexpression.
Overexpression of tHMG1 and additional overexpression of
crtI in strain YB/I/E. The results obtained so far suggest that
combined overexpression of crtI and tHMG1 in carotenoid-
producing S. cerevisiae cells results in a strain that efficiently
produces high -carotene levels. Additional overexpression of
crtI in strain YB/I/EtHMG1 indeed increased the flux
through the carotenogenic pathway and improved -carotene
production levels (Table 4). Phytoene levels decreased from
10.3 mg/g (dw) in strain YB/I/EtHMG1 to 5.4 mg/g (dw) in
strain YB/I/EtHMG1I, whereas -carotene levels in-
creased from 0.5 mg/g (dw) to 5.9 mg/g (dw). Total carotenoid
accumulation levels were similar in strain YB/I/EtHMG1
and strain YB/I/EtHMG1I (11 mg/g [dw]). The transfor-
mants were more orange than YB/I/EtHMG1 cells (Fig. 4c
and d). The absence of intermediates with a lower degree of
desaturation than -carotene (neurosporene, -zeacarotene,
and 7,8-dihydro--carotene) in strain YB/I/EtHMG1I in-
dicated that the flux through the carotenogenic pathway was
more efficient compared to that in strain YB/I/EtHMG1.
Although strains producing high levels of -carotene were
created by overexpression of tHMG1 and additional overex-
pression of crtI in strain YB/I/E, still relatively high phytoene
levels accumulated, suggesting that a limitation at the level of
phytoene desaturation still exists. Possibly, fine-tuning of
tHMG1 expression levels to more efficiently control phytoene
production might further increase -carotene production
levels.
Concluding remarks. In summary, we have been able to
construct S. cerevisiae strains that produce various amounts of
carotenoids by integration and overexpression of caroteno-
genic genes from X. dendrorhous. We succeeded in the con-
struction of a strain producing 5.9 mg -carotene/g (dw), which
is 57-fold more than previously reported for heterologous
-carotene production in S. cerevisiae (41). This was achieved
by overexpression of the catalytic domain of HMG1 from S.
cerevisiae and additional overexpression of the crtI gene from
X. dendrorhous in carotenoid-producing S. cerevisiae cells
transformed with carotenogenic genes from X. dendrorhous.
Optimizing the culturing conditions, for instance, by growing
the strains in large volumes under controlled fermentor con-
ditions, might further increase -carotene yields. This ap-
proach was successful for engineered -carotene-producing E.
coli strains (13). Possibly, -carotene production levels can be
further increased by chemical mutagenesis. This strategy has
resulted in X. dendrorhous strains with increased astaxanthin
production levels (1). The strains producing high -carotene
FIG. 4. Colors of different carotenoid-producing S. cerevisiae mu-
tants. All strains were initially transformed with YIplac211 crtYB/crtI/
crtE* to obtain carotenoid-producing cells and subsequently with the
integrated vectors containing the indicated genes. (a) Strain YB/I/E,
CEN.PK 113-5D; (b) strain YB/I/Eextra I, CEN.PK 113-6B trans-
formed with YIplac204 crtI; (c) strain YB/I/EtHMG1, CEN.PK
113-6B transformed with YIplac128 tHMG1; (d) strain YB/I/Eextra
ItHMG1, CEN.PK 113-6B transformed with YIplac128 crtI and
YIplac204 tHMG1. Individual transformants were grown for 2 days on
YNB–2% glucose medium supplemented with amino acids where re-
quired and streaked onto yeast extract–peptone–2% glucose plates.
After 3 days of incubation at 30°C, the plates were photographed.
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levels are promising for further development toward the bio-
technological production of -carotene by S. cerevisiae.
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